TrialCancer medicine2025

Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib.

Ajibade Ashaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.